Literature DB >> 8518857

Serum and urinary zinc levels in urolithiasis.

G V Rangnekar1, M S Gaur.   

Abstract

Zinc has an important place amongst inhibitors of crystallisation and crystal growth. These views are supported by in vivo and in vitro studies which suggest that the urinary zinc level is a significant factor in urolithiasis. Some recent studies have given contradictory results. Blood serum and urinary zinc levels were measured in 30 normal healthy controls and 42 stone forming patients (renal, ureteric and vesical). Statistically significant levels were found in all groups, varying according to the number of calculi. Increased urinary zinc levels and decreased serum zinc levels appear to be secondary to the process of stone formation. The role of zinc as an inhibitor of urolithiasis is questionable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518857     DOI: 10.1111/j.1464-410x.1993.tb16019.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

1.  Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.

Authors:  Irfan H Atakan; Mustafa Kaplan; Gulay Seren; Tevfik Aktoz; Hatice Gül; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Does smoking have any effect on urinary stone composition and the distribution of trace elements in urine and stones?

Authors:  Marcin Słojewski; Bogusław Czerny; Krzysztof Safranow; Marek Droździk; Andrzej Pawlik; Katarzyna Jakubowska; Maria Olszewska; Adam Gołab; Elzbieta Byra; Dariusz Chlubek; Andrzej Sikorski
Journal:  Urol Res       Date:  2009-10-14

3.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

4.  The concentration of Zn, Mg and Mn in calcium oxalate monohydrate stones appears to interfere with their fragility in ESWL therapy.

Authors:  Mehmet Turgut; Ibrahim Unal; Asiye Berber; Temir Ali Demir; Fezan Mutlu; Yüksel Aydar
Journal:  Urol Res       Date:  2008-01-05

5.  Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Parsa Yousefichaijan; Ali Cyrus; Fatemeh Dorreh; Mohammad Rafeie; Mojtaba Sharafkhah; Faryar Frohar; Fatemeh Safi
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

Review 6.  Major and trace elements in lithogenesis.

Authors:  Marcin Słojewski
Journal:  Cent European J Urol       Date:  2011-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.